Myriad Genetics | MYGN - Operating Profit


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Myriad Genetics

Myriad Genetics reported $-52200000 in Operating Profit for its fiscal quarter ending in March of 2023.


Operating Profit Change
Accelerate Diagnostics AXDX:US USD -16062000 2.1M
Agilent A:US USD 383M 43M
Becton, Dickinson and Co. BDX:US USD 628M 43M
Bruker BRKR:US USD 122.7M 8.3M
Danaher DHR:US USD 1.79B 502M
Exact Sciences EXAS:US USD -77091000 41.79M
Hologic HOLX:US USD 272.1M 9.7M
Illumina ILMN:US USD -64000000 63M
J&J JNJ:US USD -737000000 4.94B
Myriad Genetics MYGN:US USD -52200000 0
NanoString Technologies NSTG:US USD -40550000 2.13M
OraSure Technologies OSUR:US USD 24.32M 10.89M
Pacific Biosciences Of California PACB:US USD -91252000 4.17M
Quest Diagnostics DGX:US USD 305M 170M
Quidel QDEL:US USD 99.6M 13.1M
Repligen RGEN:US USD 31.26M 17.58M
Thermo Fisher Scientific TMO:US USD 1.56B 298M
Veracyte VCYT:US USD -10498000 5.08M
Waters WAT:US USD 174.17M 112.12M